Indeed, two of the examples we have highlighted, ARMCX2 and MAGEH1 (Fig. 3e, f), have previously demonstrated promoter hypermethylation and gene silencing in ovarian and liver cancer, respectively. This evidence concerns the gene MAGEH1 and liver cancer.